Geneoscopy
Geneoscopy
geneoscopy.com

Locations

St. Louis, MO, USA · North America

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Series B

founded in

2015

Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasive colonoscopy. Geneoscopy is changing that. It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications.

Something looks off?
Open jobs at Geneoscopy
Powered by Getro